Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Renders, Lutz (6602849386)"

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Exome Sequencing and Identification of Phenocopies in Patients With Clinically Presumed Hereditary Nephropathies
    (2020)
    Riedhammer, Korbinian M. (57200625458)
    ;
    Braunisch, Matthias C. (57192699344)
    ;
    Günthner, Roman (6507490502)
    ;
    Wagner, Matias (35370135300)
    ;
    Hemmer, Clara (57216548595)
    ;
    Strom, Tim M. (7102342124)
    ;
    Schmaderer, Christoph (16204132800)
    ;
    Renders, Lutz (6602849386)
    ;
    Tasic, Velibor (7003911066)
    ;
    Gucev, Zoran (15765372600)
    ;
    Nushi-Stavileci, Valbona (57193881397)
    ;
    Putnik, Jovana (14008113300)
    ;
    Stajić, Nataša (6602606131)
    ;
    Weidenbusch, Marc (44961542100)
    ;
    Uetz, Barbara (57199583178)
    ;
    Montoya, Carmen (7005889581)
    ;
    Strotmann, Peter (56286928800)
    ;
    Ponsel, Sabine (56986500900)
    ;
    Lange-Sperandio, Baerbel (6506453628)
    ;
    Hoefele, Julia (57196082805)
    Rationale & Objective: Hereditary nephropathies are clinically and genetically heterogeneous disorders. For some patients, the clinical phenotype corresponds to a specific hereditary disease but genetic testing reveals that the expected genotype is not present (phenocopy). The aim of this study was to evaluate the spectrum and frequency of phenocopies identified by using exome sequencing in a cohort of patients who were clinically suspected to have hereditary kidney disorders. Study Design: Cross-sectional cohort study. Setting & Participants: 174 unrelated patients were recruited for exome sequencing and categorized into 7 disease groups according to their clinical presentation. They included autosomal dominant tubulointerstitial kidney disease, Alport syndrome, congenital anomalies of the kidney and urinary tract, ciliopathy, focal segmental glomerulosclerosis/steroid-resistant nephrotic syndrome, VACTERL association, and “other.” Results: A genetic diagnosis (either likely pathogenic or pathogenic variant according to the guidelines of the American College of Medical Genetics) was established using exome sequencing in 52 of 174 (30%) cases. A phenocopy was identified for 10 of the 52 exome sequencing–solved cases (19%), representing 6% of the total cohort. The most frequent phenocopies (n = 5) were associated with genetic Alport syndrome presenting clinically as focal segmental glomerulosclerosis/steroid-resistant nephrotic syndrome. Strictly targeted gene panels (<25 kilobases) did not identify any of the phenocopy cases. Limitations: The spectrum of described phenocopies is small. Selection bias may have altered the diagnostic yield within disease groups in our study population. The study cohort was predominantly of non-Finnish European descent, limiting generalizability. Certain hereditary kidney diseases cannot be diagnosed by using exome sequencing (eg, MUC1-autosomal dominant tubulointerstitial kidney disease). Conclusions: Phenocopies led to the recategorization of disease and altered clinical management. This study highlights that exome sequencing can detect otherwise occult genetic heterogeneity of kidney diseases. © 2020 National Kidney Foundation, Inc.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    The multifaceted phenotypic and genotypic spectrum of type-IV-collagen-related nephropathy—A human genetics department experience
    (2022)
    Ćomić, Jasmina (57896737200)
    ;
    Riedhammer, Korbinian M. (57200625458)
    ;
    Günthner, Roman (6507490502)
    ;
    Schaaf, Christian W. (59886124500)
    ;
    Richthammer, Patrick (23983315500)
    ;
    Simmendinger, Hannes (57897933000)
    ;
    Kieffer, Donald (57897456500)
    ;
    Berutti, Riccardo (24483074500)
    ;
    Tasic, Velibor (7003911066)
    ;
    Abazi-Emini, Nora (57896737400)
    ;
    Nushi-Stavileci, Valbona (57193881397)
    ;
    Putnik, Jovana (14008113300)
    ;
    Stajic, Nataša (6602606131)
    ;
    Lungu, Adrian (35812503300)
    ;
    Gross, Oliver (21934239600)
    ;
    Renders, Lutz (6602849386)
    ;
    Heemann, Uwe (26643385000)
    ;
    Braunisch, Matthias C. (57192699344)
    ;
    Meitinger, Thomas (57215631099)
    ;
    Hoefele, Julia (57196082805)
    Disease-causing variants in COL4A3-5 are associated with type-IV-collagen-related nephropathy, a genetically and phenotypically multifaceted disorder comprising Alport syndrome (AS) and thin basement membrane nephropathy (TBMN) and autosomal, X-linked and a proposed digenic inheritance. Initial symptoms of individuals with AS are microscopic hematuria followed by proteinuria leading to kidney failure (90% on dialysis < age 40 years). In contrast, individuals with TBMN, an outdated histology-derived term, present with microscopic hematuria, only some of them develop kidney failure (>50 years of age). An early diagnosis of type-IV-collagen-related nephropathy is essential for optimized therapy and slowing of the disease. Sixty index cases, in whom exome sequencing had been performed and with disease-causing variant(s) in COL4A3-5, were evaluated concerning their clinical tentative diagnosis and their genotype. Of 60 reevaluated individuals with type-IV-collagen-related nephropathy, 72% had AS, 23% TBMN and 5% focal segmental glomerulosclerosis (FSGS) as clinical tentative diagnosis. The FSGS cases had to be re-classified as having type-IV-collagen-related nephropathy. Twelve percent of cases had AS as clinical tentative diagnosis and a monoallelic disease-causing variant in COL4A3/4 but could not be classified as autosomal dominant AS because of limited or conflicting clinical data. This study illustrates the complex clinical and genetic picture of individuals with a type IV-collagen-related nephropathy indicating the need of a refined nomenclature and the more interdisciplinary teamwork of clinicians and geneticists as the key to optimized patient care. Copyright © 2022 Ćomić, Riedhammer, Günthner, Schaaf, Richthammer, Simmendinger, Kieffer, Berutti, Tasic, Abazi-Emini, Nushi-Stavileci, Putnik, Stajic, Lungu, Gross, Renders, Heemann, Braunisch, Meitinger and Hoefele.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback